(This May 28 story has been corrected to say ‘eye drop,’ not ‘liquid medication,’ in paragraph 3 and to remove the picture) Reuters Health Information
Tag: Ophthalmology
US FDA Approves Alcon’s New Dry-eye Drug (May 28)
(This May 28 story has been corrected to say ‘eye drop,’ not ‘liquid medication,’ in paragraph 3 and to remove the picture) Reuters Health Information
Can You Eat Away the Risk for Blindness?
Although cures for age-related macular degeneration are elusive, the case for prevention through nutrition looks strong and certainly better than a shot in the eye. Medscape Medical News
Study: Dropless Cataract Surgery Slashes Drug Costs
Injection of an antibiotic and glucocorticoid after cataract surgery is far cheaper and as safe as a protocol 12 drops daily tapered over 4 weeks, a new study shows. Medscape Medical News
Office-Based Cataract Surgery Measures Up To ASC Cases
A retrospective review of 1300 cataract operations by one surgeon finds office-based surgeries are no less safe than ambulatory surgery center cases. Medscape Medical News
Safe Driving Possible Despite Loss of Visual Field
People who experience a reduced visual field as a result of glaucoma or stroke can drive as safely as those of the same age with normal vision, a recent study finds. Medscape Medical News
This Gender Logs More Eye Surgeries in Residency
Records from more than 4800 ophthalmology residents show the average number of cataract surgeries and other eye procedures could vary by gender and race or ethnicity. Medscape Medical News
ARVO Attendees Hear Call to Save National Eye Institute
An eye research advocacy group has issued an urgent plea to thwart proposals to gut federal funding for biomedical research and dismantle the National Eye Institute. Medscape Medical News
How Climate Change Threatens Eye Health
Cataracts, pink eye, and other ocular disorders are linked to heat, air pollution, and higher UV exposure. Knowable Magazine
Cataract Surgery May Be Safe Beyond A1c Cutoffs
Cataract surgery may not increase the risk for postoperative endophthalmitis or severe systemic adverse events in patients with diabetes, regardless of A1c levels, according to a recent study. Medscape Medical News
Oral, Injected Semaglutide May Pose Distinct Eye Risks
The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which also identified differences based on sex, age, and timing of onset. Medscape Medical News
Red-Light Therapy May Reduce Cone Density in Myopic Children
Medscape Medical News
Stop Smoking Now to Protect Your Vision, Experts Warn
A “meta–meta-analysis” highlights the negative effects of smoking on ocular health, particularly concerning age-related macular degeneration, cataracts, and primary open-angle glaucoma. Medscape Medical News
UK Consultants Restore Sight for 24 Injured Protesters
Two consultants from London’s Moorfields Eye Hospital restored vision for 24 young men in Bangladesh, following severe eye trauma sustained during pro-democracy protests. Medscape News UK
Social Media Aids Post-Op Care in Ectopia Lentis
Using a smartphone application for health education and reminders enhances parental understanding and boosts follow-up visits in children undergoing surgery for CEL. Medscape Medical News
Seven Years, a Hidden Metal Body, and Restored Eyesight
A metallic fragment, missed after a workplace injury, is removed 7 years later, fully restoring a 59-year-old man’s vision. Medscape UK
Early-Onset Atopic Dermatitis Raises Uveitis Risk in Kids
A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis, highlighting a need for ophthalmologic monitoring in youth. Medscape Medical News
US FDA Declines to Approve Aldeyra’s Eye Disease Drug
The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics treatment for dry eye disease, the company said on Thursday, sending its shares… Reuters Health Information
Sponsor Pulls Plug on Trials of Add-On AMD Treatment
An add-on agent designed to boost drugs that treat age-related macular degeneration failed to show any benefit in two phase 3 trials, so the sponsor halted both trials. Medscape Medical News
EMA Recommends Ryjunea for Pediatric Myopia
The atropine-based eye drop is designed to slow myopia progression in children. Medscape Medical News